Publications

Recent Publications (from NCBI PubMed)

• DFUCare: deep learning platform for diabetic foot ulcer detection, analysis, and monitoring
  Published on October 9th, 2024 Primary Author: Varun Sendilraj
• MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity
  Published on September 25th, 2024 Primary Author: Justus M Huelse
• Less Deformable Erythrocyte Subpopulations Biomechanically Induce Endothelial Inflammation in Sickle Cell Disease
  Published on August 23rd, 2024 Primary Author: Christina Caruso
• Less-deformable erythrocyte subpopulations biomechanically induce endothelial inflammation in sickle cell disease
  Published on August 23rd, 2024 Primary Author: Christina Caruso
• Single-cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in non-Hispanic Blacks
  Published on August 10th, 2024 Primary Author: Dahim Choi
• Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity with High-Density Progenitor Cell Regions Correlating with High-Risk Disease
  Published on July 9th, 2024 Primary Author: Franklin Chien
• Early Injury Landscape in Vein Harvest by Single-Cell and Spatial Transcriptomics
  Published on May 29th, 2024 Primary Author: Marina E Michaud
• A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
  Published on May 27th, 2024 Primary Author: William C Pilcher
• Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections
  Published on April 27th, 2024 Primary Author: Selwyn J Hurwitz
• Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
  Published on April 8th, 2024 Primary Author: Karuna Mittal
• Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells
  Published on April 3rd, 2024 Primary Author: Kathryn M Moore
• Single cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells
  Published on January 31st, 2024 Primary Author: Kathryn M Moore
• The Simple prEservatioN of Single cElls method for cryopreservation enables the generation of single-cell immune profiles from whole blood
  Published on December 13th, 2023 Primary Author: Sarthak Satpathy
• Integrated single-nuclei and spatial transcriptomic analysis reveals propagation of early acute vein harvest and distension injury signaling pathways following arterial implantation
  Published on November 14th, 2023 Primary Author: Marina E Michaud
• Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia
  Published on October 16th, 2023 Primary Author: Hope L Mumme
• Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia
  Published on October 5th, 2023 Primary Author: Hope Mumme
• Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
  Published on September 16th, 2023 Primary Author: Theodore S Johnson
• Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape
  Published on September 12th, 2023 Primary Author: Ramya Ganesan
• DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway
  Published on August 11th, 2023 Primary Author: Akhona Vava
• Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis
  Published on August 2nd, 2023 Primary Author: Swati S Bhasin
• The 'omics of obesity in B-cell acute lymphoblastic leukemia
  Published on May 4th, 2023 Primary Author: Delaney K Geitgey
• Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
  Published on March 27th, 2023 Primary Author: Lijun Yao
• Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma
  Published on January 26th, 2023 Primary Author: William Pilcher
• Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma
  Published on September 28th, 2022 Primary Author: Aditi Sharma
• Transcriptomics and systems biology identify non-antibiotic drugs for the treatment of ocular bacterial infection
  Published on August 29th, 2022 Primary Author: Susmita Das
• Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
  Published on June 10th, 2022 Primary Author: Brian Dobosh
• Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen
  Published on June 3rd, 2022 Primary Author: Mandakh Bekhbat
• Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care
  Published on May 11th, 2022 Primary Author: Ryan J Summers
• Survival Genie, a web platform for survival analysis across pediatric and adult cancers
  Published on February 24th, 2022 Primary Author: Bhakti Dwivedi
• Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer
  Published on February 8th, 2022 Primary Author: Fen Ma
• Single cell transcriptomic landscape of diabetic foot ulcers
  Published on January 11th, 2022 Primary Author: Georgios Theocharidis
• A Grammastola spatulata mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies
  Published on June 10th, 2021 Primary Author: David H Vandorpe
• Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
  Published on February 4th, 2021 Primary Author: Dina Stroopinsky
• ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
  Published on January 21st, 2021 Primary Author: Prateek Khanna
• Embryonic periventricular endothelial cells demonstrate a unique pro-neurodevelopment and anti-inflammatory gene signature
  Published on November 24th, 2020 Primary Author: Franciele Cristina Kipper
• A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnosis of Pancreatic Adenocarcinoma
  Published on November 2nd, 2020 Primary Author: Indu Khatri
• COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail
  Published on October 14th, 2020 Primary Author: Rimesh Pal
• SARS-CoV-2 morbidity and mortality in racial/ethnic minority populations: A window into the stress related inflammatory basis of health disparities?
  Published on October 14th, 2020 Primary Author: Bizu Gelaye
• Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers
  Published on August 9th, 2020 Primary Author: Georgios Theocharidis
• TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance
  Published on August 8th, 2020 Primary Author: Matthew R Lynch
• Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability
  Published on May 1st, 2020 Primary Author: Pedro A Martinez
• Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
  Published on January 31st, 2020 Primary Author: Jiaxuan Chen
• Topical Application of a Mast Cell Stabilizer Improves Impaired Diabetic Wound Healing
  Published on October 1st, 2019 Primary Author: Ana Tellechea
• Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
  Published on June 18th, 2019 Primary Author: Dipak Panigrahy
• Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
  Published on April 27th, 2019 Primary Author: Vera Mugoni
• TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance
  Published on March 15th, 2019 Primary Author: Matthew R Lynch
• Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
  Published on February 24th, 2019 Primary Author: Chun-Hau Chen
• Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis
  Published on January 16th, 2019 Primary Author: Indu Khatri
• Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer
  Published on September 23rd, 2018 Primary Author: Joshua W Russo
• Leukocyte Transcriptional Response in Sepsis
  Published on September 14th, 2018 Primary Author: Simon Skibsted
• Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis
  Published on August 5th, 2018 Primary Author: Alessandro Prete
• Determination of system level alterations in host transcriptome due to Zika virus (ZIKV) Infection in retinal pigment epithelium
  Published on July 27th, 2018 Primary Author: Pawan Kumar Singh
• Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
  Published on June 30th, 2018 Primary Author: Jaimie Chang
• Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
  Published on June 21st, 2018 Primary Author: Adam G Sowalsky
• Specific Transcriptome Changes Associated with Blood Pressure Reduction in Hypertensive Patients After Relaxation Response Training
  Published on April 5th, 2018 Primary Author: Manoj K Bhasin
• Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes
  Published on February 7th, 2018 Primary Author: Tiago Koppe
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E
  Published on November 22nd, 2017 Primary Author: Zeus A Antonello
• Mitochondrial Dysfunction in Atrial Tissue of Patients Developing Postoperative Atrial Fibrillation
  Published on August 2nd, 2017 Primary Author: Jelliffe Jeganathan
• Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
  Published on July 26th, 2017 Primary Author: Rebecca Herzog
• Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers
  Published on February 23rd, 2017 Primary Author: Clémence Thomas
• Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache
  Published on April 20th, 2016 Primary Author: Carlton J Perry
• Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier
  Published on March 20th, 2016 Primary Author: Manoj K Bhasin
• Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota
  Published on January 26th, 2016 Primary Author: Feng Wang
• The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival
  Published on January 6th, 2016 Primary Author: Hiroto Ohguchi
• SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1
  Published on August 25th, 2015 Primary Author: Jaíra Ferreira de Vasconcellos
• Cardiopulmonary Bypass Decreases Activation of the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway in Diabetic Human Myocardium
  Published on August 1st, 2015 Primary Author: Khurram Owais
• Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer
  Published on January 16th, 2015 Primary Author: Liang Zhang
• MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis
  Published on December 18th, 2014 Primary Author: Benjamin G Cuiffo
• HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis
  Published on March 26th, 2014 Primary Author: Mathieu Angin
• Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection
  Published on March 7th, 2014 Primary Author: Mohamed S Arredouani
• Bench-to-bedside review: future novel diagnostics for sepsis - a systems biology approach
  Published on October 8th, 2013 Primary Author: Simon Skibsted
• Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways
  Published on May 8th, 2013 Primary Author: Manoj K Bhasin
• Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival
  Published on September 6th, 2012 Primary Author: Maria Koulmanda
• A metabolic prosurvival role for PML in breast cancer
  Published on August 14th, 2012 Primary Author: Arkaitz Carracedo
• The role of TNF-α in mice with type 1- and 2- diabetes
  Published on May 19th, 2012 Primary Author: Maria Koulmanda
• High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
  Published on December 23rd, 2011 Primary Author: Xiaoen Wang
• Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy
  Published on September 21st, 2011 Primary Author: Luiz F Zerbini
• PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
  Published on September 2nd, 2011 Primary Author: Mei Tran
• RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG
  Published on June 2nd, 2011 Primary Author: Lei Yuan